NCT02338245 Study of ASLAN001 in Combination With Capecitabine in MBC That Has Failed on Prior Trastuzumab Status COMPLETED Phase PHASE2
NCT02335411 A Study of Pembrolizumab (MK-3475) in Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-059/KEYNOTE-059) Status COMPLETED Phase PHASE2
NCT02316535 Low-dose Capecitabine Adjuvant Chemotherapy for Elderly Patients With Stage II/III Colorectal Cancer Status UNKNOWN Phase PHASE3
NCT02314117 A Study of Ramucirumab (LY3009806) in Combination With Capecitabine and Cisplatin in Participants With Stomach Cancer Status COMPLETED Phase PHASE3
NCT02301143 Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC) Status COMPLETED Phase PHASE2
NCT02297230 Locally Advanced Breast Cancer: Individualized Treatment Based On Tumor Molecular Characteristics Status TERMINATED Phase PHASE1/PHASE2
NCT02294786 Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer Status TERMINATED Phase PHASE2
NCT02291289 A Study of Biomarker-Driven Therapy in Metastatic Colorectal Cancer (mCRC) Status COMPLETED Phase PHASE2
NCT02289547 Phase 3 Study of Xelox Followed by Maintenance Capecitabine in the Advanced Gastric Cancer Status UNKNOWN Phase PHASE3
NCT02288195 CONVERT: Neoadjuvant Chemotherapy Alone Versus Preoperative Chemoradiation for Locally Advanced Rectal Cancer Patients Status UNKNOWN Phase PHASE3
NCT02287129 Evaluation for the Individualization of Therapy in Adenocarcinomas of the Gastroesophageal Junction Status COMPLETED Phase PHASE2
NCT02268006 IMRT-SIB and Capecitabine in Preoperative Rectal Cancer Treatment Status UNKNOWN Phase PHASE2
NCT02253459 Clinical Study of UTD1 Injection in Combination With Capecitabine in Patients With Advanced and Metastatic Breast Cancer Status COMPLETED Phase PHASE3
NCT02250209 T- XELOX in HER2-positive Stage III Gastric Cancer After D2 Gastrectomy Status UNKNOWN Phase PHASE2
NCT02248571 Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With Bevacizumab Status COMPLETED Phase PHASE4
NCT02244489 Momelotinib Combined With Capecitabine and Oxaliplatin in Adults With Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma Status TERMINATED Phase PHASE1
NCT02243007 Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer Status TERMINATED Phase PHASE2
NCT02218164 Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma Status COMPLETED Phase PHASE2
NCT02216149 Effects of S-1 and Capecitabine on Coronary Artery Blood Flow Status TERMINATED Phase PHASE2